ABSTRACT
Improved surgical techniques and adjuvant therapies for primary rectal cancer have reduced the rates of local recurrence to less than 10 per cent.14 Surgery for LRRC, or pelvic exenteration surgery, has become more complex, requiring more radical extended surgery and the involvement of a multidisciplinary team approach.
